Activation of Urokinase Plasminogen Activator and Its Receptor Axis Is Essential for Macrophage Infiltration in a Prostate Cancer Mouse Model
Open Access
- 1 January 2011
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 13 (1), 23-30
- https://doi.org/10.1593/neo.10728
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammationJournal of Leukocyte Biology, 2009
- A novel model of bone‐metastatic prostate cancer in immunocompetent MiceThe Prostate, 2009
- Targeted Knockdown ofNotch1Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen ActivatorClinical Cancer Research, 2009
- Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate CancerCancer Research, 2007
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapyEuropean Journal of Cancer, 2006
- RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in VivoJournal of Biological Chemistry, 2005
- Inflammation and cancerNature, 2002
- Urokinase-Type Plasminogen Activator Expression in Human Prostate CarcinomasThe American Journal of the Medical Sciences, 1996
- Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase.JCI Insight, 1996
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981